THOMAS MANDAT: Open Payments
NPI 1881792794 · PARMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 12 payments from 11 companies in 2025. Trend: 2023 $315 · 2024 $86 · 2025 $365
Food & beverage: $280Education: $85
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 2 | $85 |
| SK Life Science, Inc. | 1 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $56 |
| Lilly USA, LLC | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: AFREZZA, XIFAXAN, AMYVID, INGREZZA, Dexcom G6 Transmitter, VOWST, JARDIANCE, REPATHA.
Industry payments across OH — which companies pay providers there.
